Sino-US nucleic acid detection price big public difference of a hundred times also feel expensive?

On the afternoon of June 18, a Beijing woman, MsWang, tweeted that the coronavirus nucleic acid test was expensive, scraped two times at the root of the tongue, earned 180 yuan in two seconds, and assumed that 100 million people would make 18 billion dollars for testing, and that the Ministry of Health was going to make a fortuneThis speech, directly ignited the anger of netizens, the topic of coronavirus detection costs pushed on the hot searchon the one hand, after the outbreak of the new outbreak, the epidemic-related markets, communities, Beijing high-risk streets, township residents and other 6 categories of personnel nucleic acid testing is free, but if because of the urgent need to go out of Beijing needs seven days of kernel acid test results, to the relevant network testing is chargedon the other hand, a test is not only a medical staff sampling 2 seconds, the entire test process involved in reagents, sample tubes, medical staff protective supplies, sites, etc., is a very large and complex cost systemnetizens directly said: "feel expensive, can refer to foreign.", then, in the global nucleic acid testing environment, 180 yuan / person nucleic acid testing is what level?has a diagnostic laboratory called Gibson in a Dallas, Texas, suburbIn this lab, coronavirus nucleic acid testing costs as much as $2,315 per person, and even in some patients, it gives three times the price, or $6,945 per personof course, not all diagnostic laboratories in the U.Smedical market are at such high prices, with many large laboratories offering a price of $100 per personAccording to the American Clinical Laboratory Association, its members conduct about 11 million coronavirus tests for a unit price of $95-$209why does a simple coronavirus test cost $100 in one laboratory and more than 2,000 times more in another?This returns to the basic fact of the American health care system: the government does not regulate the price of health carethis often leads to two consequences:, starting with high overall pricesMost medical bills in the United States are twice or three times as high as those in the same countryFor example, an appendectomy costs $3,050 in the UK and $6,710 in New Zealand, both of which regulate medical pricesIn the U.S., the average price of an appendectomy is $13,020followed by huge price differencesBecause each doctor's clinic or hospital has its own medical feeA study back in 2012 found that California hospitals charged between $1,529 and $182,955 for simple appendectomyas a result, the cost of testing the new crown virus varies widely, and it's nothing new in U.Shealth careIn Texas alone, testing costs range from $27 per person to $2,315 per person charged by Gibson Diagnosticssome U.Shealth policy experts to say bluntly, "I can't think of any other market other than health care." "
the recent Care Act requires insurance companies to cover the full cost of coronavirus testingThe policy inadvertently gave the green light to some medical institutions, who set unusually high fees because they knew that insurance companies were required by law to paymost medical institutions in themaintain relatively modest feesMany medical service providers are tested at a price of $50-200 per personLabCorp, one of the largest diagnostic testing companies in the United States, is priced at $100 per person for new crown virus testing some medical institutions set prices much higher For example, some emergency rooms in Texas and Oklahoma often charge patients $500-990 per person for coronavirus testing the highest percentage of high-priced testing costs in Texas, according to multiple insurers Blue Cross and Blue Shield, which provides health care services in Texas, has received more than 600 coronavirus testing bills for an average unit price of $1,114 Does higher price mean better service? not There is little evidence that higher prices are associated with better health care, and the difference between higher prices is often that service providers set higher prices for their own services the Gibson Diagnostic Stylist does not offer any particular or different technologies compared to the large diagnostic laboratory at $100/person , in the short term, this high price for coronavirus testing doesn't seem to have much effect on Americans: the federal government has set aside $1 billion for uninsured Americans to pay for their testing; for Americans with insurance, federal law requires that medics pay for the test in full and cannot claim waivers or out-of-pocket payments but in the long run, Americans will end up paying for these expensive checks in the form of higher premiums compared to the High Price Difference caused by medical suppliers' independent pricing locks in the U.S market, the overall price of coronavirus testing in China's medical market is basically maintained within 300 yuan/person range, and varies from region to region different from the U.S market, the price of the new crown test is through the collection, including health insurance, price-limiting trilogy continued to reduce prices, the current basic control of 120 yuan / person (1) collection, so that the price of testing reagents first down
modelled on drug collection, in the large amount of new crown testing kit field, Chinese medical also use the method of collection, medical control costs in the context of the central request for large-scale nucleic acid testing, Hubei Province, as the national epidemic prevention and control of the key areas, as early as April 2020 began to start the new coronavirus detection reagents centralized procurement According to the results of the public announcement, the new crown virus nucleic acid testing reagents, Mike Bio, Daan Gene, Mingde Bio, Huada Gene wholly-owned subsidiary Huada Bio 4 companies, the winning price is 16.78 yuan, 19.998 yuan, 23.90 yuan, 24.99 yuan Compared with the average purchase price in Hubei Province at the end of March 2020, the decrease was as high as 81%, and among the new crown virus antibody testing reagents, the Zhuhai Lizhu Reagent and Nanjing Novizan of the Lizhu Group were selected at 12.90 yuan and 13.89 yuan respectively This is a 72 per cent decrease from the province's average purchase price at the end of March 2020 in Hubei Province's new crown testing reagents collection, enterprise quotations become the biggest bright spot After Hubei, more and more new crown collections appeared in China Heilongjiang, Fujian, as well as Guangdong-led, including Jiangxi, Guangxi, Hunan, Chongqing, Yunnan and other 6 provinces and cities composed of procurement alliances, have carried out the new crown virus testing reagents centralized procurement the price of the new crown nucleic acid testkit was compressed again in the case of the provinces taking turns to collect the harvest Take the latest data published in Henan Province as an example On June 23, , Henan Province issued a notice on the publicity of the new coronavirus-related testing reagents centralized procurement of the network price limit The public announcement of 33 new coronavirus-related testing reagents of the centralized procurement of the network price limit After the end of the publicity period, the price limit will be implemented through the henan pharmaceutical procurement platform According to the public ity, 33 neo-coronavirus-related testing reagents, a total of 14 nucleic acid testing kits, 13 kinds of nucleic acid testing kits using fluorescent PCR method (Shanghai Rendu bionucleic acid testing kit using RNA capture probe method) Among them: the lowest price of the varieties from Shenzhen United Medicine, 12 yuan / person The price limit of the network is the same as the enterprise quotation the highest quoted varieties from Shanghai Rendu bio, 78 yuan / person; Sanxiang biological (60 yuan / person), Shushi bio (42 yuan / person), Geno bio (33 yuan / person) also gave a high price, but according to the rules, the enterprise quotation is higher than 15.6 yuan / person of the product hanging net price is 15.6 yuan / person 33 new coronavirus-related testing reagents, a total of 19 antibody detection kits (including IgM/IgG antibody detection kits), detection methods are diverse, mainly magnetic particle seone chemical luminescence method, gel gold body method Among them: the lowest quoted varieties are IgM antibody testing kits (chemical luminescence) and IgG antibody testing kits (chemical luminescence), both 5.8 yuan / person; the highest quoted varieties are from Innot (28.34 yuan / per person), Nanjing Novizan (27.78 yuan / per person), Zhuhai Lizhu reagent (25.8 yuan / per person), are colloidal gold method IgM / IgG antibody testing kit, the final net price limit of 12.99 yuan / per person in the Henan publicity of the hanging network limit notice, the biggest feature is according to different classification, different methods, give the hanging net limit price When the enterprise quote is lower than the limit price, according to the enterprise quotation hanging network, when the quotation is higher than the limit price, it is up to the enterprise's own decision, if you want to hang the net to the price limit The overall price is lower than the winning bid price at the time of the Hubei collection (2) let the new crown test into the medical insurance, control the overall service price the new crown virus testing reagents itself is only one of the components of medical expenses, only consumables collection, but also can not achieve the best control fee effect, therefore, "the new crown test ingons into the core content of the current stage." On June 19, , the Office of the State Administration of Health Care issued a Notice on Co-operation to Do a Good Job in Further Improving the Detection Capability of the New Crown Virus The document proposes that all localities should include nucleic acid testing and related consumables in the scope of medical insurance reimbursement This document contains a series of heavyweight implementation points: 1, the general implementation of open network procurement Public medical institutions should purchase new coronavirus testing reagents from the provincial pharmaceutical supplies centralized procurement platform of the province 2, testing projects do not "by disease project." Public medical institutions for the new crown virus to carry out nucleic acid, antibody testing, can directly implement the existing fee policy, no need to apply for new price items 3, a single temporary project needs to reflect the "separation of technical consumption." Sample collection, processing, marking, recovery, issuing diagnostic results, and consumables such as nasopharyngeal swabs should be combined to price items for medical services; 4, encourage the nucleic acid testing, related supplies into the health care directory On the basis of comprehensive consideration of the needs of the prevention and control of new coronavirus pneumonia and the ability to pay for medical insurance funds in the region, the nucleic acid, antibody detection projects and related consumables for the new coronavirus shall be included in the catalogue of provincial medical insurance diagnosis and treatment projects according to the procedure, and the payment conditions shall be determined simultaneously in fact, some provinces have already included nucleic acid testing in advance May 8, 2020, Heilongjiang Provincial Health Insurance Bureau issued a message, clearly the new coronavirus nucleic acid testing project into the directory of medical insurance diagnosis and treatment projects, according to Class B project management, all insured personnel due to medical needs are covered by medical insurance reimbursement in addition to Heilongjiang Province, Beijing, Hubei, Tianjin and other provinces and cities have implemented the new crown testing into the scope of medical insurance reimbursement (3) killer - price limit, not to float
price reduction is the general trend, in the new crown collection, call to be included in the medical environment, the provinces and cities directly came up with the killer - price limit on June 24, , Jiangsu Provincial Medical Security Bureau issued "on the proposed adjustment of new coronavirus pneumonia nucleic acid testing and other medical services price publicity", public price adjustment program shows that the new coronavirus nucleic acid testing (PCR method): 120 yuan / time new coronavirus antibodies (including total antibodies, IgM, IgG) detection: 40 yuan/ time this price limit, directly in Jiangsu Province, the overall new crown testing price reduced by 50% (In April, Jiangsu new coronavirus nucleic acid detection price is 240 yuan / time, new coronavirus antibody detection price is 80 yuan / item the Beijing Municipal Health Care Administration also imposed price restrictions According to the announcement, from June 25, the price of nucleic acid testing in public medical institutions in Beijing will be reduced from 180 yuan to 120 yuan per time, the price is the highest government guidance price, medical institutions are not allowed to float; the same period, Tianjin Municipal Health Insurance Bureau, the Municipal Health and Health Commission jointly issued a similar notice: the new crown virus nucleic acid testing price from 180 yuan per person to 120 yuan; that is, in the new crown test price, the government departments spare no effort, through collection, including health insurance, price-limiting trilogy continued to reduce prices, the current basic control of 120 yuan / person China's medical reform is an ongoing process, even in the face of sudden new crown outbreaks, still non-stop toward the direction of fees we have no intention of singing a hymn This time through the Sino-US new crown detection price and the mechanism behind the comparison, just want to let everyone more objectively look at the increasingly normal new crown detection and its price.